Prosthetic capsular devices, systems, and methods
The present invention relates to a prosthetic capsular bag and method for inserting the same. The prosthetic capsular bag helps to maintain the volume of the natural capsular bag, thereby stabilizing the effective lens position of an IOL so that refractive outcomes may be improved with cataract surgery. The prosthetic capsular bag further provides an integrated refractive surface, providing a means for experimentally determining an effective lens position prior to inserting an IOL.
1. A method of manufacturing an ophthalmic implant device for implantation in an eye, the method comprising:
manufacturing the ophthalmic implant device from silicone, the ophthalmic implant device configured to be inserted into a natural capsular bag of an eye after removal of a cataract, the ophthalmic implant device comprising:
an anterior side including an opening;
a posterior side; and
a deformable sidewall, the deformable sidewall forming a single continuous wall from the anterior side to the posterior side;
wherein the ophthalmic implant device is configured to mechanically maintain substantially a volume of the natural capsular bag,
wherein the ophthalmic implant device is configured to mechanically self-expand;
wherein the ophthalmic implant device is adapted to contain one or more intraocular lenses.
2. The method of claim 1 , further comprising manufacturing the ophthalmic implant device from silicone and a secondary a biologically-compatible, optically clear material.
3. The method of claim 2 , wherein the biologically-compatible, optically clear material comprises at least one of the following materials: collamer and acrylic.
4. The method of claim 1 , wherein the ophthalmic implant device is foldable.
5. The method of claim 1 , wherein the one or more intraocular lens is configured to be placed in physical contact with a peripheral internal surface of the deformable sidewall.
6. The method of claim 1 , wherein the one or more intraocular lens comprises a refractive surface.
7. The method of claim 6 , wherein the exterior contour is adapted to mechanically maintain the ophthalmic implant device at a specific position and orientation within the eye.
8. The method of claim 1 , wherein the one or more intraocular lens comprises one or more haptics.
9. The method of claim 8 , wherein the one or more haptics are configured to physically contact a peripheral internal surface of the deformable sidewall.
10. The method of claim 1 , wherein the one or more intraocular lens includes at least one or more of the following characteristics: concave, convex, spherical, aspheric, wavefront, multifocal diffractive, multifocal refractive, multifocal zonal, accommodative, UV filtering, diffractive chromatic aberration reducing, and astigmatism correcting toric form.
11. The method of claim 1 , wherein a portion of the ophthalmic implant device is adapted to lie within the natural capsular bag and is shaped such that an exterior contour of the ophthalmic implant device conforms to a shape of the natural capsular bag.
12. The method of claim 1 , wherein the ophthalmic implant device is a biological compatible, deformable ophthalmic implant device.
13. The method of claim 1 , wherein the ophthalmic implant device is substantially discoid in shape.
14. The method of claim 1 , wherein the ophthalmic implant device is approximately the size, shape, and volume of a natural human lens.
15. The method of claim 1 , wherein the opening is configured to be open when the ophthalmic implant device is inserted in the eye.
16. The method of claim 1 , wherein the ophthalmic implant device comprises a prosthetic barrier separating an anterior segment and posterior segment of the eye.
17. The method of claim 1 , wherein the ophthalmic implant device possesses sufficient elasticity to resume its pre-folded shape once positioned in the eye.
18. The method of claim 1 , wherein the deformable sidewall is oriented between the anterior side and the posterior side.
19. The method of claim 1 , the ophthalmic implant device configured to receive pharmaceuticals for delivery to the eye.
20. The method of claim 1 , the ophthalmic implant device configured to enable a future lens exchange of the one or more intraocular lenses.
21. A method of manufacturing an ophthalmic implant device for implantation in an eye, the method comprising:
manufacturing the ophthalmic implant device from acrylic, the ophthalmic implant device configured to be inserted into a natural capsular bag of an eye after removal of a cataract, the ophthalmic implant device comprising:
an anterior side including an opening;
a posterior side; and
a deformable sidewall, the deformable sidewall forming a single continuous wall from the anterior side to the posterior side;
wherein the ophthalmic implant device is configured to mechanically maintain substantially a volume of the natural capsular bag,
wherein the ophthalmic implant device is configured to mechanically self-expand;
wherein the ophthalmic implant device is adapted to contain one or more intraocular lenses.
22. The method of claim 21 , further comprising manufacturing the ophthalmic implant device from acrylic and a secondary a biologically-compatible, optically clear material.
23. The method of claim 22 , wherein the biologically-compatible, optically clear material comprises at least one of the following materials: collamer and silicone.
24. The method of claim 21 , wherein the ophthalmic implant device is foldable.
25. The method of claim 21 , wherein the one or more intraocular lens is configured to be placed in physical contact with a peripheral internal surface of the deformable sidewall.
26. The method of claim 21 , wherein the one or more intraocular lens comprises a refractive surface.
27. The method of claim 21 , wherein the one or more intraocular lens comprises one or more haptics.
28. The method of claim 27 , wherein the one or more haptics are configured to physically contact a peripheral internal surface of the deformable sidewall.
29. The method of claim 21 , wherein the one or more intraocular lens includes at least one or more of the following characteristics: concave, convex, spherical, aspheric, wavefront, multifocal diffractive, multifocal refractive, multifocal zonal, accommodative, UV filtering, diffractive chromatic aberration reducing, and astigmatism correcting toric form.
30. The method of claim 21 , the ophthalmic implant device configured to receive pharmaceuticals for delivery to the eye.